Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -314.66% is 422% below its 5-year average of -60.31%, near the low end of its 5-year range (-314.66%–-26.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 89.09% below its 12-month average of -166.41%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -314.66%.
RETURN ON INVESTED CAPITAL (ROIC)
-314.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-166.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-79.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-60.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-89.09%
CURRENT VS 3Y AVG
-293.37%
CURRENT VS 5Y AVG
-421.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 825 covered companies
CURRENT VS SECTOR MEDIAN
-782.38%
vs the sector median at left
Pyxis Oncology, Inc.
Market Cap
$129.56M
Return on Invested Capital (ROIC)
-314.66%
TTM Avg
-166.41%
3Y Avg
-79.99%
5Y Avg
-60.31%
Market Cap
$127.29M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-346.83%
3Y Avg
-231.85%
5Y Avg
-139.34%
Market Cap
$126.92M
Return on Invested Capital (ROIC)
-82.87%
TTM Avg
-100.14%
3Y Avg
-98.73%
5Y Avg
-97.80%
Market Cap
$132.64M
Return on Invested Capital (ROIC)
-21.42%
TTM Avg
-8.92%
3Y Avg
-14.86%
5Y Avg
-16.42%
Market Cap
$132.66M
Return on Invested Capital (ROIC)
-7.01%
TTM Avg
-1.96%
3Y Avg
-0.91%
5Y Avg
1.75%
Market Cap
$133.72M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$124.74M
Return on Invested Capital (ROIC)
-74.08%
TTM Avg
-72.79%
3Y Avg
-71.36%
5Y Avg
-64.12%
Market Cap
$134.99M
Return on Invested Capital (ROIC)
-0.98%
TTM Avg
-12.17%
3Y Avg
-37.42%
5Y Avg
-26.70%
Market Cap
$135.33M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $129.56M | -314.66% | -166.41% | -79.99% | -60.31% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | N/A | -346.83% | -231.85% | -139.34% |
| Entera Bio Ltd. (ENTX)vs › | $126.92M | -82.87% | -100.14% | -98.73% | -97.80% |
| Health Catalyst, Inc. (HCAT)vs › | $132.64M | -21.42% | -8.92% | -14.86% | -16.42% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $132.66M | -7.01% | -1.96% | -0.91% | 1.75% |
| LifeMD, Inc. (LFMD)vs › | $133.72M | -143.97% | -52.39% | -55.03% | -91.26% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.74M | -74.08% | -72.79% | -71.36% | -64.12% |
| Organigram Global Inc. (OGI)vs › | $134.99M | -0.98% | -12.17% | -37.42% | -26.70% |
| Freenome, Inc. (FRNM)vs › | $135.33M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $122.91M | -137.40% | -133.78% | -372.93% | -315.43% |
ROIC
-314.7%
ROE
-775.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -314.66% |
| 2026-03-31 | -173.38% |
| 2025-12-31 | -119.93% |
| 2025-09-30 | -123.16% |
| 2025-06-30 | -100.90% |
| 2025-03-31 | -87.92% |
| 2024-12-31 | -64.13% |
| 2024-09-30 | -38.38% |
| 2024-06-30 | -35.91% |
| 2024-03-31 | -32.44% |
| 2023-12-31 | -55.55% |
| 2023-09-30 | -64.66% |
| 2023-06-30 | -63.52% |
| 2023-03-31 | -66.03% |
| 2022-12-31 | -68.70% |
| 2022-09-30 | -49.77% |
| 2022-06-30 | -37.41% |
| 2022-03-31 | -28.00% |
| 2021-12-31 | -26.68% |
| 2021-09-30 | -47.18% |
| 2021-06-30 | -35.66% |
| 2020-12-31 | -199.54% |
